Fırat Uyulur

机构：Queen Mary University of London, Barts Cancer Institute · ORCID：0000-0002-9281-9616

发表论文 9 篇 · 总被引 281 次 · h-index 6

代表论文

• Bromodomain inhibition of the coactivators CBP/EP300 facilitate cellular reprogramming (2019 · Nature Chemical Biology · 被引 103)
• Identification of SERPINE1 as a Regulator of Glioblastoma Cell Dispersal with Transcriptome Profiling (2019 · Cancers · 被引 89)
• The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma (2019 · Cell Death and Disease · 被引 39)
• EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities (2022 · Cell Death and Disease · 被引 22)
• Nuclear FGFR1 promotes pancreatic stellate cell-driven invasion through up-regulation of Neuregulin 1 (2022 · Oncogene · 被引 19)
• EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities (2021 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 8)